Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2463838017 | Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension (product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2469029013 | Erythromycin ethylsuccinate + sulphisoxazole acetyl 200mg/600mg oral suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 2469508010 | Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Is a | Product containing erythromycin (medicinal product) | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Is a | Product containing sulfafurazole (medicinal product) | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Is a | Erythromycin-containing product in oral dose form | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Erythromycin (substance) | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Sulfafurazole | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Is a | Product containing erythromycin ethylsuccinate and sulfafurazole acetyl | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Sulfafurazole acetyl | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Erythromycin ethylsuccinate (substance) | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Has manufactured dose form | Oral suspension | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Has active ingredient | Bactericide | false | Inferred relationship | Some | ||
| Erythromycin ethylsuccinate + sulfisoxazole acetyl 200mg/600mg oral suspension | Is a | Product containing sulfafurazole in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
FHIR